Division of Nephrology, Mount Sinai Medical Center, New York, NY 10029-657, USA.
Transplantation. 2010 Jan 27;89(2):215-21. doi: 10.1097/TP.0b013e3181c353e5.
Chronic kidney disease is a frequent complication in orthotopic liver transplant (OLT) recipients, observed in 10% to 60% after 5 years.
We analyzed clinical and pathological data from 81 OLT recipients who developed impaired kidney function with a serum creatinine greater than or equal to 1.5 mg/dL or new proteinuria on dipstick urinalysis. All patients underwent percutaneous kidney biopsy. The most common reason for liver transplantation was hepatitis C virus infection. The mean time until biopsy was 4.89 years. At the time of biopsy, the mean serum creatinine was 2.0 mg/dL, Modified Diet of Renal Disease glomerular filtration rate was 38.7 mL/min, and 24-hr urine protein was 1.37 g.
All biopsies demonstrated glomerular abnormalities, 42% showed primary glomerular diseases, and only 16% had evidence of calcineurin inhibitor toxicity. Electron microscopy was performed on 74 biopsies and podocyte effacement was detected in 88%. Mean postbiopsy follow-up was 20 months; eight patients progressed to end-stage renal disease.
This study demonstrates universal glomerular abnormalities in kidney biopsies after OLT. The pathology is suggestive of diabetic nephropathy and hypertensive change, but there are also specific glomerular disease processes present. There is little calcineurin inhibitor toxicity in this group. These findings underscore the importance of understanding the causes of kidney disease in the constantly changing liver transplant population, and the need to change current management of these patients.
慢性肾脏病是肝移植(OLT)受者的常见并发症,5 年后发生率为 10%至 60%。
我们分析了 81 例因血清肌酐≥1.5mg/dL 或尿蛋白试纸检测到新的蛋白尿而导致肾功能受损的 OLT 受者的临床和病理数据。所有患者均接受经皮肾活检。肝移植的最常见原因是丙型肝炎病毒感染。活检时的平均血清肌酐为 2.0mg/dL,改良肾脏病饮食肾小球滤过率为 38.7ml/min,24 小时尿蛋白为 1.37g。
所有活检均显示肾小球异常,42%为原发性肾小球疾病,仅 16%有钙调神经磷酸酶抑制剂毒性的证据。74 例活检进行了电子显微镜检查,88%检测到足细胞消失。活检后平均随访 20 个月,8 例进展至终末期肾病。
本研究表明 OLT 后肾脏活检普遍存在肾小球异常。病理表现提示糖尿病肾病和高血压改变,但也存在特定的肾小球疾病过程。该组中钙调神经磷酸酶抑制剂毒性较小。这些发现强调了了解不断变化的肝移植人群中肾脏疾病病因的重要性,以及改变这些患者现有管理方法的必要性。